Trials / Completed
CompletedNCT04538976
Copd Exacerbation and Pulmonary Hypertension Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Chronic Obstructive Pulmonary Disease Trial Network, Denmark · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This trial will investigate whether patiens admitted with an acute exacerbation of chronic obstructive lung disease and pulmonary hypertension will benefit from a targeted pharmacological treatment.
Detailed description
During admittance due to acute exacerbation of chronic obstructive lung disease will patience have an echocardiography to examine their pulmonary pressure. If patient have a tricuspidal return gradient above 40 mmHg, they will receive treatment with a phosphordiesterase-5-inhibitor, Sildenafil.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil | Sildenafil in standard dosage |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2024-03-15
- Completion
- 2024-03-15
- First posted
- 2020-09-04
- Last updated
- 2025-03-13
Locations
5 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04538976. Inclusion in this directory is not an endorsement.